Keywords: prilosec, market, share, slumps, usa, astrazeneca, lost

Prilosec market share slumps 50% in USA

Article | 20 January 2003

Print This

AstraZeneca has lost almost half the market share for its blockbusterantiulcerant Prilosec (omeprazole) in the USA since the launch of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in